Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage

Journal of Alzheimer's Disease

Volumn 17, Issue 3, 2009, Pages 531-539

  Liang, Zhihou ^a   Liu, Fei ^a   Iqbal, Khalid ^a   Grundke Iqbal, Inge ^a   Gong, Cheng Xin ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Glutamate receptors; Kainic acid; Phosphorylation; Protein kinases; Protein phosphatase 2A; Tau

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLUTAMATE RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; KAINIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; EXCITOTOXICITY; MALE; MOUSE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION;

EID: 67849111942     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1069     Document Type: Article

References (57)

1. Wang Q, Yu S, Simonyi A, Sun GY, Sun AY (2005) Kainic acid-mediated excitotoxicity as a model for neurodegenera- tion. Mol Neurobiol 31, 3-16.
2. Mattson MP (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 3, 65-94.
3. Iqbal K, Alonso A del C, Chohan MO, El-Akkad E, Gong C, Khatoon S, Liu F, Grundke-Iqbal I (2007) Molecular basis of tau protein pathology: role of abnormal hyperphosphory- lation. In Neurobiology of Alzheimer's Disease, Dawbarn D, Allen SJ, eds. Oxford University Press, New York, pp. 111-131.
4. Wang JZ, Liu F (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148-175.
5. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS,Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089.
6. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101, 10804-10809.
7. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2006) Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. J Alzheimers Dis 9, 1-12.
8. Alonso AD, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly oftau into tangles of paired helical filamentsβstraight filaments. Proc Natl Acad Sci USA 98, 6923-6928.
9. Pei JJ, Gong CX, Iqbal K, Grundke-Iqbal I, Wu QL, Win- blad B, Cowburn RF (1998) Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J Neural Transm 105, 69-83.
10. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56, 70-78.
11. Liang Z, Liu F, Iqbal K, Grundke-Iqbal I, Wegiel J, Gong CX (2008) Decrease of Protein Phosphatase 2A and its Association with Accumulation and Hyperphosphorylation ofTau in Down Syndrome. J Alzheimers Dis 13, 295-302.
12. Murray KJ, England PJ, Lynham JA, Mills D, Schmitz-Peiffer C, Reeves ML (1990) Use of a synthetic dodecapep- tide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem J 267,703-708.
13. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5to the regulation of tau phosphorylation. Eur J Neurosci 22,1942-1950.
14. Gong CX, Grundke-Iqbal I, Iqbal K (1994) Dephosphoryla- tion ofAlzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61, 765-772.
15. Gong CX, Wang JZ, Iqbal K, Grundke-Iqbal I (2003) Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci Lett 340, 107-110.
16. Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBOJ12, 803-808.
17. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
18. Tsai LH, Lee MS, Cruz J (2004) Cdk5, atherapeutic target for Alzheimer's disease? Biochim Biophys Acta 1697, 137-142.
19. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262β356. FEBSLett 490, 15-22.
20. Wang JZ, Grundke-Iqbal I, Iqbal K (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25, 59-68.
21. 2+ββcalmodulin- dependent protein kinase II. J Biol Chem 277, 20991-20998.
22. Hanson PI, Meyer T, Stryer L, Schulman H (1994) Dual role ofcalmodulin in autophosphorylation ofmultifunctional CaM kinase may underlie decoding of calcium signals. Neuron 12,943-956.
23. Meyer T, Hanson PI, Stryer L, Schulman H (1992) Calmod- ulin trapping by calcium-calmodulin-dependent protein ki- nase. Science 256, 1199-1202.
24. Robertson J, Loviny TL, Goedert M, Jakes R, Murray KJ, Anderton BH, Hanger DP (1993) Phosphorylation of tau by cyclic-AMP-dependent protein kinase. Dementia 4, 256-263.
25. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, Davies P (1999) cAMP-dependent protein kinase phospho- rylations on tau in Alzheimer's disease. JNeurosci 19, 7486-7494.
26. Sun L, Wang X, Liu S, Wang Q, Wang J, Bennecib M, Gong CX, Sengupta A, Grundke-Iqbal I, Iqbal K (2005) Bilateral injection ofisoproterenol into hippocampus induces Alzheimerlike hyperphosphorylation of tau and spatial memory deficit in rat. FEBSLett 579, 251-258.
27. Liu HN, Larocca JN, Almazan G (1999) Molecular pathways mediating activation by kainate of mitogen-activated protein kinase in oligodendrocyte progenitors. Brain Res Mol Brain Res 66, 50-61.
28. Mao L, Tang Q, Samdani S, Liu Z, Wang JQ (2004) Regulation ofMAPKβERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur J Neurosci 19, 1207-1216.
29. Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, KosikKS (1994) Secreted beta-amyloid precursor protein stimulates mitogen- activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci USA 91, 7104-7108.
30. Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G (2007) Vascular oxidative stress in Alzheimer disease. J Neurol Sci 257,240-246.
31. Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke- Iqbal I, Iqbal K (2003) Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1β2, MEK1β2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol 163, 845-858.
32. Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K, Gong CX (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. JBiol Chem 280, 37755-37762.
33. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2005) Post-translational modifications of tau protein in Alzheimer's dis-ease. JNeural Transm 112, 813-838.
34. Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, Seereer am A, Reynolds CH, Ward MA, Anderton BH (2007) Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem 282, 23645-23654.
35. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519.
36. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B (1986) Defective brain microtubule assembly in Alzheimer's disease. Lancet 2, 421-426.
37. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089-1099.
38. Alonso AD, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of mi- crotubules in Alzheimer disease. Proc Natl Acad Sci USA 91,5562-5566.
39. Alonso AD, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K (2004) Promotion of hyperphosphorylation by frontotem- poral dementia tau mutations. J Biol Chem 279, 34873-34881.
40. Fath T, Eidenmuller J, Brandt R (2002) Tau-mediated cytotox- icity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22, 9733-9741.
41. Perez M, Hernandez F, Gomez-Ramos A, Smith M, Perry G, Avila J (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur J Biochem 269, 1484-1489.
42. Simon D, Benitez MJ, Gimenez-Cassina A, Garrido JJ, Bhat RV, Diaz-Nido J, Wandosell F (2008) Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216β279. JNeurosci Res 86, 668-674.
43. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I,Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275, 5535-5544.
44. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mum-by MC (1996) Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17, 1201-1207.
45. Goedert M, Jakes R, Qi Z, Wang JH, Cohen P (1995) Protein phosphatase 2A is the major enzyme in brain that dephospho- rylates tau protein phosphorylated by proline-directed protein kinases orcyclic AMP-dependentproteinkinase. JNeurochem 65, 2804-2807.
46. Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ (2008) Tau hyperphosphorylation correlates with reduced methylation ofprotein phosphatase 2A. Neurobiol Dis 31, 386-394.
47. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phos- phoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61, 921-927.
48. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Phosphatase activity toward abnormally phosphory-lated tau: decrease in Alzheimer disease brain. J Neurochem 65, 732-738.
49. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 168, 402-412.
50. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Spe- ciale S, White CL, 3rd (2004) Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63, 287-301.
51. Goodenough S, Conrad S, Skutella T, Behl C (2004) Inactiva- tion ofglycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo. Brain Res 1026, 116-125.
52. Crespo-Biel N, Canudas AM, Camins A, Pallas M (2007) Kainate induces AKT, ERK and cdk5βGSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus. Neurochem Int 50, 435-442.
53. Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T (2004) Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin- dependent kinase 5 (cdk5) activator p35 in cultured rat hip- pocampal neurons. Neurosci Lett 368, 181-185.
54. Grabauskas G, Lancaster B, O'Connor V, Wheal HV (2007) Protein kinase signalling requirements for metabotropic action ofkainate receptors in rat CA1 pyramidal neurones. JPhysiol 579, 363-373.
55. Jones TL, Sorkin LS (2005) Activated PKA and PKC, but not CaMKIIalpha, are required for AMPAβKainate-mediated pain behavior in the thermal stimulus model. Pain 117, 259-270.
56. Savinainen A, Garcia EP, Dorow D, Marshall J, Liu YF (2001) Kainate receptor activation induces mixed lineage kinase- mediated cellular signaling cascades via post-synaptic density protein 95. JBiol Chem 276, 11382-11386.
57. Park HJ, Kim HJ, Park HJ, Ra J, Zheng LT, Yim SV, Chung JH (2008) Protective effect oftopiramate on kainic acid-induced cell death in mice hippocampus. Epilepsia 49, 163-167.